PaxMedica, Inc. · OTC:PXMD

PaxMedica, Inc. financial statements

PaxMedica, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018
Revenue00000
Research and development3.92M1.79M2.23M936.8K484.1K
Selling, general and administrative12.2B8.82M4.97M4.63M114.5K
Operating income-16.1M-10.6M-7.20M-5.57M-598.6K
Depreciation and amortization2.13M5.90M173.4K53.5K171.9K
EBITDA-14.0M-4.70M-7.02M-5.51M-426.7K
Interest expense9.16K5.24K2.81M609.5K00
Income before tax-18.3M-14.8M-10.2M-7.83M-598.6K
Income tax-167.9K4.19M2.81M663.0K-171.9K
Net income-18.3M-14.8M-13.0M-8.49M-598.6K
Earnings per share, basic-11.00-28.79-18.81-14.41-1.02

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents4.71M1.90M444.1K1.12M24.9K9.32K
Receivables00
Current assets5.68M2.20M444.1K1.12M24.9K9.32K
Total assets5.68M2.20M648.9K1.12M24.9K9.32K
Accounts payable830.2K722.0K736.3K346.1K41.0K2.45K
Current liabilities1.80M2.10M10.8M5.75M123.2K6.60K
Total debt173.5K611.6K
Total liabilities2.30M2.10M10.8M5.75M123.2K6.60K
Shareholders' equity3.39M108.8K-10.1M-4.63M-98.3K2.72K
Shares outstanding1.66M514.2K692.9K589.2K589.2K9.86M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-10.8M-6.07M-5.51M-2.35M-419.4K-279.9K
Capital spending000000
Free cash flow-10.8M-6.07M-5.51M-2.35M-419.4K-279.9K
Cash from investing-7.70K
Cash from financing13.6M7.53M4.83M3.45M435.0K300.0K
Dividends paid-11.9B-35.0K
Share buybacks-196.0K-35.0K
Change in cash2.81M1.46M-679.5K1.10M15.6K12.4K